APS was detected in 61 (81%) patients with IgA aCL versus 51 (45%) patients without these antibodies (χ2 = 23.96; p < 0.0001; odds ratio (OR), 5.26; 95% confidence interval (CI), 2.63–11.11). This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.